Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs Daniel H. Solomon, MD, MPH, Joel M. Kremer, MD, Mark Fisher, MD, Jeffrey R. Curtis, MD, MPH, Victoria Furer, MD, MPH, Leslie R. Harrold, MD, MPH, Marc C. Hochberg, MD, MPH, George Reed, PhD, Peter Tsao, MSc, Jeffrey D. Greenberg, MD, MPH Seminars in Arthritis and Rheumatism Volume 43, Issue 4, Pages (February 2014) DOI: /j.semarthrit Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions
Fig. 1 Seminars in Arthritis and Rheumatism , DOI: ( /j.semarthrit ) Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions
Fig. 2 Seminars in Arthritis and Rheumatism , DOI: ( /j.semarthrit ) Copyright © 2014 Elsevier Inc. Terms and Conditions Terms and Conditions